This FDA Approval Could Be Your Next 33% Gain

Posted On Apr 10, 2014 By Rick Pearson

This stock should jump 33% in the next two months — when two catalysts open wide!


Subscribe to Kinetic Profits Today!

Kinetic Profits uses an arsenal of computing power to give you a statistical edge over Wall Street. Our proprietary Archimedes trading platform finds a stock's strongest periods year after year — and alerts you instantly so you can act on that information. Our real-world tests show that Archimedes can successfully identify upward moves in stocks with 93.5% accuracy. Now's the time to harness the power of this "quant" system for yourself.

Subscribe Today!